Repatha is now the first and only PCSK9 inhibitor to demonstrate significant reduction of cardiovascular events as both primary and secondary prevention
The FDA also expanded Repatha’s use as monotherapy to include patients with homozygous familial hypercholesterolemia
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
The company has reported total income of Rs. 628.4 crores during the period ended March 31, 2025
Bayer expects 2025 to be the most difficult year of its turnaround
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
More than 40 types of Amyloid proteins are discovered till date
Subscribe To Our Newsletter & Stay Updated
